Additive effects of the risk alleles of PNPLA3 and TM6SF2 on non-alcoholic fatty liver disease (NAFLD) in a Chinese population

Frontiers in Genetics

Volumn 7, Issue AUG, 2016, Pages

  Wang, Xiaoliang ^a   Liu, Zhipeng ^b   Wang, Kai ^c   Wang, Zhaowen ^a   Sun, Xing ^a   Zhong, Lin ^a   Deng, Guilong ^a   Song, Guohe ^a   Sun, Baining ^a   Peng, Zhihai ^a   Liu, Wanqing ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PURDUE UNIVERSITY   (United States)

^c ZHENGZHOU CHILDREN S HOSPITAL   (China)

Author keywords

Additive effects; Chinese; NAFLD; PNPLA3; TM6SF2

Indexed keywords

GENOMIC DNA; GLUCOKINASE REGULATORY PROTEIN; LYSOPHOSPHOLIPASE LIKE 1 PROTEIN; MEMBRANE PROTEIN; NEUROCAN PROTEIN; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; TRANSMEMBRANE 6 SUPERFAMILY 2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSMEMBRANE 6 SUPERFAMILY 2 GENE;

EID: 84988442792     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2016.00140     Document Type: Article

References (27)

1. Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., and Bellentani, S. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44-52. doi: 10.1002/hep.20734.
2. Chalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., et al. (2010). Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 139, 1567-1576, 1576.e1-1576.e6. doi: 10.1053/j.gastro.2010.07.057.
3. Donati, B., Motta, B. M., Pingitore, P., Meroni, M., Pietrelli, A., Alisi, A., et al. (2016). The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. Hepatology 63, 787-798. doi: 10.1002/hep.28370.
4. Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., et al. (2015). Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 61, 506-514. doi: 10.1002/hep.27490.
5. Fan, J. G. (2013). Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J. Gastroenterol. Hepatol. 28(Suppl. 1), 11-17. doi: 10.1111/jgh.12036.
6. Genomes Project, C., Auton, A., Brooks, L. D., Durbin, R. M., Garrison, E. P., Kang, H. M., et al. (2015). A global reference for human genetic variation. Nature 526, 68-74. doi: 10.1038/nature15393.
7. Goffredo, M., Caprio, S., Feldstein, A. E., D'Adamo, E., Shaw, M. M., Pierpont, B., et al. (2016). Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: a multiethnic study. Hepatology 63, 117-125. doi: 10.1002/hep.28283.
8. He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., et al. (2010). A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706-6715. doi: 10.1074/jbc.M109.064501.
9. Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., et al. (2011). Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1082-1090. doi: 10.1002/hep.24452.
10. Hernaez, R., McLean, J., Lazo, M., Brancati, F. L., Hirschhorn, J. N., Borecki, I. B., et al. (2013). Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin. Gastroenterol. Hepatol. 11, 1183-1190 e1182. doi: 10.1016/j.cgh.2013.02.011.
11. Huang, Y., Cohen, J. C., and Hobbs, H. H. (2011). Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286, 37085-37093. doi: 10.1074/jbc.M111.290114.
12. Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjaerg-Hansen, A., et al. (2014). Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356. doi: 10.1038/ng.2901.
13. Lin, Y. C., Chang, P. F., Chang, M. H., and Ni, Y. H. (2014). Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am. J. Clin. Nutr. 99, 869-874. doi: 10.3945/ajcn.113.079749.
14. Liu, Y. L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B., et al. (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat. Commun. 5:4309. doi: 10.1038/ncomms5309.
15. Mahdessian, H., Taxiarchis, A., Popov, S., Silveira, A., Franco-Cereceda, A., Hamsten, A., et al. (2014). TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. Proc. Natl. Acad. Sci. U.S.A. 111, 8913-8918. doi: 10.1073/pnas.1323785111.
16. Palmer, N. D., Musani, S. K., Yerges-Armstrong, L. M., Feitosa, M. F., Bielak, L. F., Hernaez, R., et al. (2013). Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology 58, 966-975. doi: 10.1002/hep.26440.
17. Pirazzi, C., Valenti, L., Motta, B. M., Pingitore, P., Hedfalk, K., Mancina, R. M., et al. (2014). PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Hum. Mol. Genet. 23, 4077-4085. doi: 10.1093/hmg/ddu121.
18. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575. doi: 10.1086/519795.
19. Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., et al. (2008). Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465. doi: 10.1038/ng.257.
20. Schwimmer, J. B., Celedon, M. A., Lavine, J. E., Salem, R., Campbell, N., Schork, N. J., et al. (2009). Heritability of nonalcoholic fatty liver disease. Gastroenterology 136, 1585-1592. doi: 10.1053/j.gastro.2009.01.050.
21. Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. M., Gromada, J., et al. (2015). Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61, 108-118. doi: 10.1002/hep.27242.
22. So, H. C., Gui, A. H., Cherny, S. S., and Sham, P. C. (2011). Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 35, 310-317. doi: 10.1002/gepi.20579.
23. Sookoian, S., Castano, G. O., Scian, R., Mallardi, P., Fernandez Gianotti, T., Burgueno, A. L., et al. (2015). Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology 61, 515-525. doi: 10.1002/hep.27556.
24. Sookoian, S., and Pirola, C. J. (2011). Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883-1894. doi: 10.1002/hep.24283.
25. Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., et al. (2011). Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7:e1001324. doi: 10.1371/journal.pgen.1001324.
26. Wang, X., Liu, Z., Peng, Z., and Liu, W. (2015). The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese. J. Hepatol. 62, 1438-1439. doi: 10.1016/j.jhep.2015.01.040.
27. Zeng, M. D., Fan, J. G., Lu, L. G., Li, Y. M., Chen, C. W., Wang, B. Y., et al. (2008). Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J. Dig. Dis. 9, 108-112. doi: 10.1111/j.1751-2980.2008.00331.x.